NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Diver,

I agree with you the CRL bought Cognate because of it's relationship with NWBO, however, the question is, does that relationship still exist, or must it be reestablished as approval approaches. I did suggest another possibility in a prior post in which a partnership, to be announced when a certain milestone was achieved, would have the partner responsible for production. I still believe that CRL will be making the vaccine, but if they don't have that established contractually, anything is possible.

The FlaskWork device should be a total game changer. If it's available prior to approval, it would be possible for NWBO to consider doing all vaccine production themselves, perhaps in a new FlaskWork facility or under a FlaskWork division. Certainly this would take substantial funds, but with higher share prices I believe investors will agree with a substantial increase in authorized shares, whether they bring in billions in a partnership, or run an offering to bring in hundreds of millions, I believe the company could afford such expansion if that's what they determined to do.

I'm not suggesting that's what they're planning, but I would think that CRL would want to have itself protected against such a decision by having a contractual tie with NWBO. I believe that CRL, if it wished, is large enough to become an equity partner with NWBO, rather than a BP. I don't know that the benefit would be as great in terms of dealing with the regulators, but their could be some great synergies.

I believe that personalized products will be an area of tremendous growth over the next several decades. If CRL were looking to be a leader in this area, partnering or acquiring NWBO could be a great move for them.

Gary